vs
Side-by-side financial comparison of ALPHA PRO TECH LTD (APT) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
ALPHA PRO TECH LTD is the larger business by last-quarter revenue ($13.9M vs $13.8M, roughly 1.0× Gossamer Bio, Inc.). ALPHA PRO TECH LTD runs the higher net margin — 5.0% vs -342.3%, a 347.4% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 0.3%).
Alpha Pro Tech Ltd is a leading developer, manufacturer and marketer of disposable protective apparel, face masks, and building supply products including weather-resistant barriers. It primarily serves the healthcare, industrial, and construction sectors, with core operating markets concentrated in North America.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
APT vs GOSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $13.9M | $13.8M |
| Net Profit | $698.0K | $-47.2M |
| Gross Margin | 37.1% | — |
| Operating Margin | 6.9% | -333.6% |
| Net Margin | 5.0% | -342.3% |
| Revenue YoY | 0.3% | 47.1% |
| Net Profit YoY | -17.6% | -43.0% |
| EPS (diluted) | $0.06 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.9M | $13.8M | ||
| Q3 25 | $14.8M | $13.3M | ||
| Q2 25 | $16.7M | — | ||
| Q1 25 | $13.8M | — | ||
| Q4 24 | $13.8M | — | ||
| Q3 24 | $14.3M | — | ||
| Q2 24 | $16.3M | $95.8M | ||
| Q1 24 | $13.5M | $0 |
| Q4 25 | $698.0K | $-47.2M | ||
| Q3 25 | $976.0K | $-48.2M | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $613.0K | — | ||
| Q4 24 | $847.0K | — | ||
| Q3 24 | $862.0K | — | ||
| Q2 24 | $1.6M | $49.2M | ||
| Q1 24 | $576.0K | $-41.9M |
| Q4 25 | 37.1% | — | ||
| Q3 25 | 39.7% | — | ||
| Q2 25 | 36.8% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 37.6% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 42.0% | — | ||
| Q1 24 | 40.2% | — |
| Q4 25 | 6.9% | -333.6% | ||
| Q3 25 | 7.4% | -369.4% | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 10.5% | 54.3% | ||
| Q1 24 | 2.4% | — |
| Q4 25 | 5.0% | -342.3% | ||
| Q3 25 | 6.6% | -362.7% | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 10.1% | 51.4% | ||
| Q1 24 | 4.3% | — |
| Q4 25 | $0.06 | $-0.21 | ||
| Q3 25 | $0.09 | $-0.21 | ||
| Q2 25 | $0.12 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $0.15 | $0.22 | ||
| Q1 24 | $0.05 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $17.0M | $136.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $62.5M | $-122.8M |
| Total Assets | $74.1M | $172.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.0M | $136.9M | ||
| Q3 25 | $17.7M | $180.2M | ||
| Q2 25 | $14.5M | — | ||
| Q1 25 | $13.4M | — | ||
| Q4 24 | $18.6M | — | ||
| Q3 24 | $18.4M | — | ||
| Q2 24 | $16.2M | $354.5M | ||
| Q1 24 | $18.5M | $244.4M |
| Q4 25 | $62.5M | $-122.8M | ||
| Q3 25 | $62.5M | $-82.3M | ||
| Q2 25 | $62.2M | — | ||
| Q1 25 | $61.7M | — | ||
| Q4 24 | $62.2M | — | ||
| Q3 24 | $62.1M | — | ||
| Q2 24 | $62.0M | $81.5M | ||
| Q1 24 | $61.6M | $26.7M |
| Q4 25 | $74.1M | $172.2M | ||
| Q3 25 | $73.9M | $208.8M | ||
| Q2 25 | $73.2M | — | ||
| Q1 25 | $72.2M | — | ||
| Q4 24 | $73.7M | — | ||
| Q3 24 | $73.3M | — | ||
| Q2 24 | $72.7M | $373.4M | ||
| Q1 24 | $72.7M | $259.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $318.0K | $-48.3M |
| Free Cash FlowOCF − Capex | $51.0K | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 1.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $318.0K | $-48.3M | ||
| Q3 25 | $3.9M | $-36.2M | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $5.3M | — | ||
| Q2 24 | $-873.0K | $116.3M | ||
| Q1 24 | $-1.2M | $-52.3M |
| Q4 25 | $51.0K | — | ||
| Q3 25 | $3.8M | — | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $-4.1M | — | ||
| Q4 24 | $970.0K | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $-1.3M | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 25.9% | — | ||
| Q2 25 | 11.7% | — | ||
| Q1 25 | -29.6% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | -6.2% | — | ||
| Q1 24 | -9.3% | — |
| Q4 25 | 1.9% | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 0.8% | 0.0% | ||
| Q1 24 | 0.6% | — |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 4.02× | — | ||
| Q2 25 | 1.68× | — | ||
| Q1 25 | -6.46× | — | ||
| Q4 24 | 2.85× | — | ||
| Q3 24 | 6.18× | — | ||
| Q2 24 | -0.53× | 2.36× | ||
| Q1 24 | -2.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APT
| Other | $7.3M | 53% |
| Disposable Protective Apparel | $6.6M | 47% |
GOSS
Segment breakdown not available.